NEWTON, Mass. and BIDDEFORD, Maine, Dec. 06, 2017 (GLOBE NEWSWIRE) -- MariMed Inc., (OTCQB:MRMD) today announced a licensing agreement whereby Canuvo, Inc., will manufacture and distribute MariMed Kalm Fusion™ and Betty’s Eddies™ branded medical cannabis products in the state of Maine. The initial products
will include Kalm-Corn™ (popcorn) and MariMelts™ (sublingual oral strips) in THC and CBD formulations. The agreement with
Canuvo is the second licensing partnership that MariMed has added since announcing a national expansion initiative for its branded products in November. MariMed currently has licensed
products available in Delaware, Illinois, Maryland, and Rhode Island, with products becoming available in Nevada, Maine, and
Massachusetts in Q1 2018.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/47bf54f9-eebc-455c-8a19-47e6d0ab98c8.
Canuvo is the premier vertically integrated seed to sale medical cannabis company in Maine, with a new state of the art 120,000
sq. ft. cultivation and manufacturing facility in western Maine. Its founders and principals Glenn Peterson, a board member of the
National Cannabis Industry Association (NCIA), and Sage Peterson, CEO of Canuvo, have implemented best practices which are evident
in the quality of their medical cannabis and infused products sold at their Biddeford dispensary. Licensed patients who
purchase products are constantly educated as to the benefits of medical cannabis.
“Glenn and Sage are two extremely knowledgeable and well respected cannabis experts who run one of the premier operations in the
U.S., so it is especially gratifying to have them embrace our products,” stated Tim Shaw, MariMed Chief Operations Officer.
“We are excited to formalize our relationship with them to use MariMed’s proprietary processes, formulations, and marketing to
bring Kalm Fusion and Betty’s Eddies products in a variety of easy to use, discrete ingestion options to the patients of
Maine.”
“MariMed has created outstanding products from their cultivation techniques all the way through dosing and packaging,” stated
Glenn Peterson. “We see this as the beginning of a long and mutually beneficial relationship, that will also benefit our
patients as they have access to new, easy to use products.”
Search us and post about us on social media with the hash tag #MedicatedByMarimed:
Twitter: @MariMedInc
Facebook: @MariMedInc
Instagram: MariMedInc
YouTube: MariMedInc
About MariMed Inc.:
MariMed is an industry leader in the development and operation of
state licensed regulatory compliant cannabis cultivation, production, and dispensary facilities in multiple states across the
country. These facilities are models of excellence in horticultural principals, cannabis production, product development, and
dispensary operations. MariMed is on the forefront of precision dosed branded products for the treatment of specific medical
symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to
numerous additional states encompassing thousands of dispensaries. MariMed Inc., is one of the 17 top-performing public
cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (www.marijuanaindex.com) and CannabIndex. For additional information, visit www.MarimedAdvisors.com
About Canuvo, Inc.
Canuvo, founded in 2011, is one of 8 licensed medical dispensaries in the state of Maine. Vertically integrated, Canuvo
cultivates, manufactures, and retails its own products in its state of the art facilities. Canuvo employs best practices, including
naturally grown cannabis (no pesticides), super clean environment, and top-notch genetics, coupled with strict standards throughout
the entire cultivation and post-production process to ensure the highest quality medical grade cannabis and cannabis infused
products. Canuvo’s edibles and tinctures are crafted with the same high standards as its flowers. The Company’s mission is to
connect customers with information and support in medical cannabis use. Visit Canuvo.org for more information.
MariMed Contacts:
Business Development
Jon Levine, CFO, MariMed, Inc.
+1 844-244-0200
Investor Relations
Tyler Troup, Circadian Group
tyler@circadian-group.com
+1 (866) 950 8300
Media Relations
Julie Shepherd, Accentuate PR
Julie@accentuatepr.com
+1 847-275-3643
Forward Looking Statements:
This release contains certain forward-looking statements and
information relating to MariMed Inc., that is based on the beliefs of MariMed Inc. management, as well as assumptions made by and
information currently available to the Company. Such statements reflect the current views of the Company with respect to future
events including estimates and projections about its business based on certain assumptions of its management, including those
described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are
difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the
economic environment and changes in technology. Additional risk factors are included in the Company's public filings with the SEC.
Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein
as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected" or words of a similar nature.
The Company does not intend to update these forward-looking statements. None of the content of any of the websites of any other
party referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company
assumes no responsibility for any of such content.
![Primary Logo](https://resource.globenewswire.com/Resource/Download/2adb00c7-818a-4cb9-aac0-60a4d2f643eb?size=1)
![](http://www.globenewswire.com/newsroom/ti?ndecode=NzA2MzkjNzA0NDI2NA==)